FI63062C - Foerfarande foer framstaellning av de farmaceutiskt aktiva aminosockerderivaten trestatin a trestatin b och trestatin c - Google Patents

Foerfarande foer framstaellning av de farmaceutiskt aktiva aminosockerderivaten trestatin a trestatin b och trestatin c Download PDF

Info

Publication number
FI63062C
FI63062C FI790486A FI790486A FI63062C FI 63062 C FI63062 C FI 63062C FI 790486 A FI790486 A FI 790486A FI 790486 A FI790486 A FI 790486A FI 63062 C FI63062 C FI 63062C
Authority
FI
Finland
Prior art keywords
trestatin
höh
trestatins
isp
water
Prior art date
Application number
FI790486A
Other languages
English (en)
Finnish (fi)
Other versions
FI790486A (fi
FI63062B (fi
Inventor
Yasuji Suhara
Kiyoshi Ogawa
Kazuteru Yokose
Kimihiro Watanabe
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI790486A publication Critical patent/FI790486A/fi
Application granted granted Critical
Publication of FI63062B publication Critical patent/FI63062B/fi
Publication of FI63062C publication Critical patent/FI63062C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99Enzyme inactivation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI790486A 1978-02-14 1979-02-14 Foerfarande foer framstaellning av de farmaceutiskt aktiva aminosockerderivaten trestatin a trestatin b och trestatin c FI63062C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB583478 1978-02-14
GB583478 1978-02-14

Publications (3)

Publication Number Publication Date
FI790486A FI790486A (fi) 1979-08-15
FI63062B FI63062B (fi) 1982-12-31
FI63062C true FI63062C (fi) 1983-04-11

Family

ID=9803510

Family Applications (1)

Application Number Title Priority Date Filing Date
FI790486A FI63062C (fi) 1978-02-14 1979-02-14 Foerfarande foer framstaellning av de farmaceutiskt aktiva aminosockerderivaten trestatin a trestatin b och trestatin c

Country Status (26)

Country Link
US (1) US4273765A (fr)
EP (1) EP0003616B1 (fr)
JP (1) JPS54163511A (fr)
AR (1) AR219150A1 (fr)
AT (1) AT367451B (fr)
AU (1) AU527318B2 (fr)
CA (1) CA1121290A (fr)
DE (2) DE2905649A1 (fr)
DK (1) DK149599C (fr)
ES (1) ES477653A1 (fr)
FI (1) FI63062C (fr)
FR (1) FR2416901A1 (fr)
GR (1) GR72817B (fr)
HU (1) HU181442B (fr)
IE (1) IE47916B1 (fr)
IL (1) IL56626A0 (fr)
LU (1) LU80906A1 (fr)
MC (1) MC1253A1 (fr)
NL (1) NL7901182A (fr)
NO (1) NO153011C (fr)
NZ (1) NZ189625A (fr)
PH (1) PH15084A (fr)
PT (1) PT69218A (fr)
SE (1) SE7901276L (fr)
YU (1) YU41437B (fr)
ZA (1) ZA79528B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166093D1 (en) * 1981-01-05 1984-10-18 Takeda Chemical Industries Ltd N-substituted pseudo-aminosugars, their production and use
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4885361A (en) * 1987-07-31 1989-12-05 Hoffmann-La Roche Inc. Sulfated oligosaccharides
ATE132269T1 (de) * 1990-11-30 1996-01-15 Monoclonetics Int Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
PT1157696E (pt) * 2000-05-24 2007-01-31 Pfizer Tratamento da acidose ruminal com inibidores da alfa-amilase
US7022684B2 (en) * 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
KR20060109926A (ko) 2003-11-19 2006-10-23 메타베이시스 테라퓨틱스, 인크. 새로운 인-함유 갑상선 호르몬 모방약들
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
ATE439347T1 (de) * 2004-11-23 2009-08-15 Warner Lambert Co 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
BRPI0911063A2 (pt) 2008-04-11 2016-11-01 Astellas Pharma Inc composto aminoaçúcar e processo para produção do mesmo
EP2810951B1 (fr) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
CA2799708A1 (fr) 2010-05-21 2011-11-24 Pfizer Inc. 2-phenylbenzoylamides
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
MY188344A (en) 2012-03-09 2021-12-01 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
CA2905438A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
CA2905435A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
PT3004138T (pt) 2013-06-05 2024-06-18 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos
CA2959208C (fr) 2014-08-29 2023-09-19 Tes Pharma S.R.L. Derives de pyrimidine et utilisation comme inhibiteurs de .alpha.-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
EP3526199B1 (fr) 2016-10-14 2022-04-13 Tes Pharma S.r.l. Inhibiteurs de la semialdéhyde décarboxylase de l'acide alpha-amino-bêta-carboxymuconique
CA3119509A1 (fr) 2018-11-20 2020-05-28 Tes Pharma S.R.L Inhibiteurs de la semialdehyde decarboxylase de l'acide alpha-amino-beta-carboxymuconique
SG11202107614PA (en) 2019-01-18 2021-08-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) * 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
DE2347782C3 (de) * 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
USRE29903E (en) 1975-03-19 1979-02-06 American Cyanamid Company Antibacterial antibiotics AM31α, AM31β and AM31γ
DE2614393C3 (de) * 1976-04-02 1980-04-03 Bayer Ag, 5090 Leverkusen Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
SE7901276L (sv) 1979-08-15
PH15084A (en) 1982-07-02
AU527318B2 (en) 1983-02-24
MC1253A1 (fr) 1980-01-14
YU34879A (en) 1983-01-21
FI790486A (fi) 1979-08-15
DE2962165D1 (en) 1982-03-25
YU41437B (en) 1987-06-30
ZA79528B (en) 1980-02-27
PT69218A (en) 1979-03-01
FI63062B (fi) 1982-12-31
NL7901182A (nl) 1979-08-16
IE790274L (en) 1979-08-14
NZ189625A (en) 1981-05-01
JPS54163511A (en) 1979-12-26
NO153011C (no) 1986-01-02
EP0003616A2 (fr) 1979-08-22
DK149599C (da) 1987-06-01
DE2905649A1 (de) 1979-08-16
AT367451B (de) 1982-07-12
LU80906A1 (de) 1980-09-24
IE47916B1 (en) 1984-07-25
EP0003616A3 (en) 1979-09-05
FR2416901B1 (fr) 1980-10-24
ES477653A1 (es) 1980-03-01
DK149599B (da) 1986-08-04
IL56626A0 (en) 1979-05-31
FR2416901A1 (fr) 1979-09-07
HU181442B (en) 1983-07-28
NO153011B (no) 1985-09-23
NO790469L (no) 1979-08-15
US4273765A (en) 1981-06-16
AR219150A1 (es) 1980-07-31
DK61179A (da) 1979-08-15
GR72817B (fr) 1983-12-06
AU4402879A (en) 1979-08-23
JPS643877B2 (fr) 1989-01-23
ATA108879A (de) 1981-11-15
CA1121290A (fr) 1982-04-06
EP0003616B1 (fr) 1982-02-24

Similar Documents

Publication Publication Date Title
FI63062C (fi) Foerfarande foer framstaellning av de farmaceutiskt aktiva aminosockerderivaten trestatin a trestatin b och trestatin c
EP0063456B1 (fr) Pseudoaminosucres, leur préparation et utilisation
EP0287110A2 (fr) Antibiotiques glycopeptidiques pa-45052
US4710564A (en) Anthracycline compounds
EP0871638B1 (fr) Nouveau derive amino-oligoside et son procede de preparation
US4550159A (en) Anthracycline compounds
KR920001448B1 (ko) Bbm-2478 항생제 착화합물
EP0274545B1 (fr) Nouvelles substances dc-92b et dc-92d, et procede de preparation desdites substances
GB2060629A (en) Antibiotic substance and production and use thereof
US4595698A (en) Physiologically active substance, arphamenine and production thereof
US5451581A (en) Antibiotic LL-14E605β and O-methyl-LL-14E605β
US4565861A (en) Serirubicum
US4632917A (en) Pseudooligosaccharides with an α-glucosidase-inhibiting action, their use and pharmaceutical products
KR830001068B1 (ko) 아미노당 유도체의 제조방법
DK166025B (da) Efomycin g, dets fremstilling og anvendelse, midler med indhold deraf, dyrefoder, drikkevand og tilsaetningsstoffer dertil med indhold af efomycin g og fremgangsmaade til fremstilling af midlerne
JPH0576958B2 (fr)
EP0399444B1 (fr) Antibiotique à activité carcinostatique ou antitumorale, conagénine, sa préparation et ses applications
KR790001709B1 (ko) 아미노-슈가 화합물의 제조방법
FI63964B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara aminosockerderivat
EP0387830A2 (fr) Anthracyclines, micro-organismes pour leur production et procédé pour leur préparation
JPH0571234B2 (fr)
JPH0571599B2 (fr)
IE44803B1 (en) Amino-sugar derivatives
JPH064668B2 (ja) 新規アントラサイクリン抗生物質
JPS60248614A (ja) 抗腫瘍剤

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE AG